Why the study?
Recent breakthroughs in HF treatment and updated classifications necessitated translating new evidence into clinical practice to improve HF care in China.
Population
Patients with HF in China
Design
Clinical practice guideline
Loading...
Updates HF management for Chinese clinicians; extends prior consensus with recent trial evidence.
The 2024 Chinese Guidelines for the Diagnosis and Treatment of Heart Failure provide updated, evidence-based recommendations incorporating recent breakthroughs in HF therapy.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: